Stockscreener 앱 받기
2.98
5.70%
-0.18
시간 외 거래:
2.95
-0.03
-1.01%
전일 마감가:
$3.16
열려 있는:
$3.22
하루 거래량:
620.34K
Relative Volume:
0.07
시가총액:
$17.59M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.2344
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
+2.41%
1개월 성능:
-2.30%
6개월 성능:
+181.13%
1년 성능:
+46.31%
1일 변동 폭
$2.95
$3.52
1주일 범위
$2.88
$3.52
52주 변동 폭
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
2.98 | 21.52M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
Measuring Tharimmune Inc.’s beta against major indicesWeekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Volume spikes in Tharimmune Inc. stock – what they meanOptions Play & Low Drawdown Investment Ideas - newser.com
Is now a turning point for Tharimmune Inc.2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Tharimmune Stockholders Approve Key Strategic Proposals - TipRanks
Can volume confirm reversal in Tharimmune Inc.Weekly Investment Report & Entry Point Confirmation Signals - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Tharimmune (NASDAQ:THAR) - Defense World
What analysts say about Tharimmune Inc stockShort Selling Opportunities & Exceptional Profit Growth - earlytimes.in
Tharimmune Inc Stock Analysis and ForecastOptions Trading Strategies & Affordable Trading Strategies - earlytimes.in
Candlestick signals on Tharimmune Inc. stock todayTrade Exit Summary & Reliable Intraday Trade Alerts - newser.com
Tharimmune Amends Warrants Agreement to Boost Liquidity - TipRanks
Tharimmune amends warrants to make 3.4 million shares immediately exercisable - Investing.com
Analyzing recovery setups for Tharimmune Inc. investorsMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com
Tick level data insight on Tharimmune Inc. volatilityJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
What does recent volatility data suggest for Tharimmune Inc.Gap Down & Comprehensive Market Scan Insights - newser.com
Why Tharimmune Inc. is moving todayWeekly Gains Summary & Safe Entry Point Identification - newser.com
Wall Street Zen Upgrades Tharimmune (NASDAQ:THAR) to Hold - Defense World
Tharimmune (NASDAQ:THAR) Trading Down 2.1% – What’s Next? - Defense World
Pleasing Signs As A Number Of Insiders Buy Tharimmune Stock - Yahoo Finance
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl - El Paso Times
Is Tharimmune Inc a good long term investmentRisk Adjusted Returns & Capital Efficiency Improvement - earlytimes.in
Published on: 2025-09-27 14:56:49 - newser.com
Tharimmune Inc. stock prediction for this weekJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tharimmune Inc 주식 (THAR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Parikh Sanam | Director |
Jun 20 '25 |
Buy |
1.45 |
1,000 |
1,450 |
1,770 |
| Appajosyula Sireesh | Chief Executive Officer |
Jun 20 '25 |
Buy |
1.48 |
61,496 |
90,973 |
64,868 |
| Parikh Sanam | Director |
May 15 '25 |
Buy |
1.30 |
770 |
1,001 |
770 |
| MILBY RANDY | CEO |
Dec 19 '24 |
Buy |
2.12 |
4,600 |
9,752 |
17,534 |
| Appajosyula Sireesh | Chief Operating Officer |
Nov 13 '24 |
Buy |
2.02 |
5,000 |
10,096 |
10,758 |
5.74%
자본화:
|
볼륨(24시간):